{"id":"W4400239828","doi":"10.1007/s13555-024-01200-5","title":"Practical Management of the JAK1 Inhibitor Abrocitinib for Atopic Dermatitis in Clinical Practice: Special Safety Considerations","year":2024,"lang":"en","type":"article","venue":"Dermatology and Therapy","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; SKiN Health; Queen's University","funders":"LEO Pharma; Bausch Health; Astellas Pharma; Galderma; Bristol-Myers Squibb; Eli Lilly and Company; Ortho Dermatologics; Sanofi Genzyme; Incyte; Castle Biosciences; Dermira; Regeneron Pharmaceuticals; Celgene; Valeant Pharmaceuticals International; Sanofi; Amgen; Pfizer","keywords":"Atopic dermatitis; Dermatology; Clinical Practice; Medicine; Family medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00186214,0.0005369963,0.0009682217,0.0008042763,0.000563297,0.001669014,0.0007161505,0.002539906,0.003847477],"category_scores_gemma":[0.005245555,0.0002250343,0.0008607624,0.0004927503,0.0006463388,0.002116719,0.0009450386,0.003272006,0.002388612],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005233315,"about_ca_system_score_gemma":0.001223402,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007905746,"about_ca_topic_score_gemma":0.001832923,"domain_scores_codex":[0.9986197,0.0004644249,0.0002932549,0.0001092444,0.0004339796,0.00007935582],"domain_scores_gemma":[0.9980361,0.0009825211,0.0003121214,0.00005348453,0.0004339675,0.0001817844],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001441564,0.0001137905,0.002000702,0.004903981,0.00008366571,0.009785036,0.0007673766,0.0005770809,0.002500352,0.003137928,0.1164456,0.8595404],"study_design_scores_gemma":[0.0001516219,0.0003459871,0.00392831,0.005650008,0.000187128,0.06522168,0.0008083574,0.0007225742,0.001161718,0.005772802,0.9159777,0.00007216725],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.008519956,0.874333,0.01580866,0.07040453,0.003004373,0.0001973924,0.0001600737,0.0003321539,0.02723977],"genre_scores_gemma":[0.06748606,0.8251008,0.03345634,0.04794945,0.01272121,0.0003859184,0.0003833605,0.0001699038,0.01234694],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.003847477,"threshold_uncertainty_score":0.01287109,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03828749553093205,"score_gpt":0.3944068089206649,"score_spread":0.3561193133897329,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}